Revised SPC: Yervoy (ipilimumab) concentrate for solution for infusion

SPC has been updated to reflect licence extension covering use in combination with nivolumab for the first‑line treatment of adult patients with unresectable malignant pleural mesothelioma.

electronic Medicines compendium